RECOVERY / DIRECT CATALOG PRICING
TB-500 / Wolverine Peptide
FDA identifies the substance called TB-500 as the seven-amino-acid thymosin beta-4 fragment LKKTETQ; it is distinct from the full 43-amino-acid thymosin beta-4 protein.
- Format
- Lyophilized research vial
- Listed formats
- 2
- Available now
- 2
- Catalog class
- Recovery
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
FDA identifies the substance called TB-500 as the seven-amino-acid thymosin beta-4 fragment LKKTETQ; it is distinct from the full 43-amino-acid thymosin beta-4 protein.
The recovery classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Recovery
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- 2 formats currently orderable
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
FDA identifies the substance called TB-500 as the seven-amino-acid thymosin beta-4 fragment LKKTETQ; it is distinct from the full 43-amino-acid thymosin beta-4 protein.
- Research covered
- Researchers tested full-length thymosin beta-4 and the synthetic LKKTETQ actin-binding fragment in diabetic and aged mouse wound-repair models.
- Important limit
- FDA reports no identified human exposure data for thymosin beta-4 fragment, and the catalog's added name 'Wolverine Peptide' does not further define its chemical identity.
FACTUAL FAQ
TB-500 / Wolverine Peptide catalog questions
What formats are currently listed?
5 mg, 10 mg. Current price and stock state appear above.
What did researchers study?
Researchers tested full-length thymosin beta-4 and the synthetic LKKTETQ actin-binding fragment in diabetic and aged mouse wound-repair models.
What is the most important evidence limit?
FDA reports no identified human exposure data for thymosin beta-4 fragment, and the catalog's added name 'Wolverine Peptide' does not further define its chemical identity.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →
